QUANTRES ASSET MANAGEMENT Ltd Buys New Holdings in Metlife Inc (NYSE:MET)

QUANTRES ASSET MANAGEMENT Ltd purchased a new stake in shares of Metlife Inc (NYSE:MET) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 25,300 shares of the financial services provider’s stock, valued at approximately $1,279,000.

A number of other hedge funds have also recently added to or reduced their stakes in the business. BlackRock Inc. raised its position in Metlife by 2.2% in the second quarter. BlackRock Inc. now owns 69,957,359 shares of the financial services provider’s stock worth $3,843,457,000 after purchasing an additional 1,481,489 shares in the last quarter. Vanguard Group Inc. raised its position in Metlife by 2.1% in the second quarter. Vanguard Group Inc. now owns 66,723,143 shares of the financial services provider’s stock worth $3,665,769,000 after purchasing an additional 1,358,523 shares in the last quarter. Franklin Resources Inc. raised its position in Metlife by 1.6% in the second quarter. Franklin Resources Inc. now owns 25,704,204 shares of the financial services provider’s stock worth $1,412,189,000 after purchasing an additional 414,032 shares in the last quarter. Epoch Investment Partners Inc. raised its position in Metlife by 208.5% in the third quarter. Epoch Investment Partners Inc. now owns 10,291,110 shares of the financial services provider’s stock worth $534,623,000 after purchasing an additional 6,954,917 shares in the last quarter. Finally, TD Asset Management Inc. raised its position in Metlife by 20.5% in the third quarter. TD Asset Management Inc. now owns 6,268,938 shares of the financial services provider’s stock worth $325,671,000 after purchasing an additional 1,067,700 shares in the last quarter. Institutional investors own 76.24% of the company’s stock.

In other news, insider Christopher G. Townsend sold 55,712 shares of Metlife stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $54.29, for a total value of $3,024,604.48. Following the completion of the transaction, the insider now owns 25,181 shares of the company’s stock, valued at approximately $1,367,076.49. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Christopher G. Townsend sold 82,731 shares of Metlife stock in a transaction dated Friday, November 3rd. The shares were sold at an average price of $54.60, for a total transaction of $4,517,112.60. Following the completion of the transaction, the insider now directly owns 49,660 shares of the company’s stock, valued at approximately $2,711,436. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

Several research firms have recently weighed in on MET. ValuEngine raised shares of Metlife from a “buy” rating to a “strong-buy” rating in a report on Tuesday, September 26th. Deutsche Bank began coverage on shares of Metlife in a report on Tuesday, January 2nd. They set a “hold” rating and a $55.00 price objective for the company. Zacks Investment Research lowered shares of Metlife from a “hold” rating to a “sell” rating in a report on Tuesday, January 2nd. TheStreet raised shares of Metlife from a “c+” rating to a “b” rating in a research note on Wednesday, October 4th. Finally, B. Riley reissued a “neutral” rating on shares of Metlife in a research note on Monday, November 6th. Two equities research analysts have rated the stock with a sell rating, ten have given a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the stock. Metlife presently has a consensus rating of “Hold” and an average target price of $57.90.

Shares of Metlife Inc (NYSE:MET) opened at $53.49 on Friday. Metlife Inc has a twelve month low of $44.26 and a twelve month high of $55.91. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.31. The firm has a market cap of $56,290.00, a price-to-earnings ratio of 116.28, a price-to-earnings-growth ratio of 1.20 and a beta of 1.49.

Metlife (NYSE:MET) last issued its quarterly earnings data on Wednesday, November 1st. The financial services provider reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.19. Metlife had a negative net margin of 0.75% and a positive return on equity of 8.81%. The business had revenue of $16.10 billion for the quarter, compared to analyst estimates of $15.47 billion. During the same period last year, the business posted $1.28 earnings per share. The firm’s quarterly revenue was up 1.7% on a year-over-year basis. sell-side analysts anticipate that Metlife Inc will post 4.4 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 13th. Shareholders of record on Monday, February 5th will be paid a $0.40 dividend. The ex-dividend date of this dividend is Friday, February 2nd. This represents a $1.60 annualized dividend and a yield of 2.99%. Metlife’s payout ratio is currently 347.83%.

ILLEGAL ACTIVITY WARNING: This news story was originally posted by Week Herald and is the sole property of of Week Herald. If you are reading this news story on another publication, it was illegally stolen and republished in violation of international copyright & trademark legislation. The original version of this news story can be viewed at https://weekherald.com/2018/01/12/quantres-asset-management-ltd-acquires-new-holdings-in-metlife-inc-met.html.

Metlife Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply